Drug Safety

Aims & Scope

The premier international journal covering the disciplines of pharmacovigilance, pharmacoepidemiology, benefit-risk assessment, risk management and medication error prevention. Drug Safety advances the rational use of pharmacotherapy by publishing reviews and original research articles offering guidance for safe and effective drug utilization and prescribing. As a hybrid journal, Drug Safety does not charge authors to publish using the traditional subscription-based publishing route, but does offer the option to publish accepted articles open access if authors so wish or if their funders require (more information). Drug Safety also offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content (more information). Drug Safety is the official journal of the International Society of Pharmacovigilance (ISoP). The official representative for the Society is Dr Omar Aimer, ISoP President ([email protected]). Contact: For more information about the journal, including pre-submission enquiries, please contact Nitin Joshi at [email protected]

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Subject Classification